共 46 条
- [21] Catalytic, asymmetric addition of 1,3-dicarbonyl compounds to nitroalkenes, and the synthesis of endothelin-a antagonist ABT-546.ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B236 - B236Barnes, DMJi, JGKing, SAWittenberger, SJMorton, HEWagaw, SHPreskill, MZhang, JFickes, MGFitzgerald, MA
- [22] Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft modelCANCER BIOLOGY & THERAPY, 2009, 8 (20) : 1940 - 1946Yang, Kwang MoRussell, JamesLupu, Mihaela E.Cho, HyungJoonLi, Xiao-FengKoutcher, Jason A.Ling, C. Clifton
- [23] Organocatalytic Enantioselective Conjugate Addition of Nitromethane to Benzylidene-2-Benzoyl Acetate: Asymmetric Synthesis of ABT-627, an Endothelin Receptor AntagonistFRONTIERS IN CHEMISTRY, 2020, 8Hajra, SaumenAziz, Sk MohammadJana, BibekanandaHazra, Sunit
- [24] In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancerCANCER RESEARCH, 2007, 67 (08) : 3818 - 3826Banerjee, SanjeevHussain, MahaWang, ZhiweiSaliganan, AllenChe, MingxinBonfil, DanielCher, MichaelSarkar, Fazlul H.
- [25] Antihypertensive and renoprotective effects of ABT-627 and chlorthalidone treatment in Dahl S rats on a high salt high fat dietFASEB JOURNAL, 2013, 27Jin, ChunhuaPollock, David M.
- [26] 'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effectsJOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S48 - S52Chiou, WJWessale, JLvon Geldern, TOpgenorth, TJWu-Wong, JR
- [27] Editor's Note: In vitro and In vivo Molecular Evidence for Better Therapeutic Efficacy of ABT-627 and Taxotere Combination in Prostate CancerCANCER RESEARCH, 2018, 78 (18) : 5465 - 5465Banerjee, S.Hussain, M.Wang, Z.Saliganan, A.Che, M.Bonfil, D.
- [28] Development of a catalytic enantioselective conjugate addition of 1,3-dicarbonyl compounds to nitroalkenes for the synthesis of endothelin-A antagonist ABT-546. Scope, mechanism, and further application to the synthesis of the antidepressant rolipramJOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (44) : 13097 - 13105Barnes, DMJi, JGFickes, MGFitzgerald, MAKing, SAMorton, HEPlagge, FAPreskill, MWagaw, SHWittenberger, SJZhang, J
- [29] An efficient and convergent synthesis of the potent and selective H3 antagonist ABT-239TETRAHEDRON, 2006, 62 (18) : 4584 - 4589Ku, YYPu, YMGrieme, TSharma, PBhatia, AVCowart, M
- [30] Process development of an efficient and scalable synthesis of ABT-239, a potent and selective H3 antagonistABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U3100 - U3100Ku, Yi-YinPu, Yu-MingGrieme, TimSharma, PadamBhatia, Ashok V.Cowart, Marlon